The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer

被引：75

作者：

van Es, N. ^{[1
]}

Franke, V. F. ^{[1
]}

Middeldorp, S. ^{[1
]}

Wilmink, J. W. ^{[2
]}

Buller, H. R. ^{[1
]}

机构：

[1] Acad Med Ctr, Dept Vasc Med, Room F4-136,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[2] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands

来源：

THROMBOSIS RESEARCH | 2017年 / 150卷

关键词：

Deep vein thrombosis; Pulmonary embolism; Pancreatic cancer; Risk prediction; PATIENTS RECEIVING CHEMOTHERAPY; AMBULATORY PATIENTS; THROMBOPROPHYLAXIS; THROMBOSIS; MODEL;

D O I：

10.1016/j.thromres.2016.12.013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：30 / 32

页数：3

共 10 条

[1] Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer [J].

Agnelli, Giancarlo ;

George, Daniel J. ;

Kakkar, Ajay K. ;

Fisher, William ;

Lassen, Michael R. ;

Mismetti, Patrick ;

Mouret, Patrick ;

Chaudhari, Umesh ;

Lawson, Francesca ;

Turpie, Alexander G. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (07) :601-609

[2] Prediction of venous thromboembolism in cancer patients [J].

Ay, Cihan ;

Dunkler, Daniela ;

Marosi, Christine ;

Chiriac, Alexandru-Laurentiu ;

Vormittag, Rainer ;

Simanek, Ralph ;

Quehenberger, Peter ;

Zielinski, Christoph ;

Pabinger, Ingrid .

BLOOD, 2010, 116 (24) :5377-5382

[3] Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis [J].

Horsted, Freesia ;

West, Joe ;

Grainge, Matthew J. .

PLOS MEDICINE, 2012, 9 (07)

[4] Development and validation of a predictive model for chemotherapy-associated thrombosis [J].

Khorana, Alok A. ;

Kuderer, Nicole M. ;

Culakova, Eva ;

Lyman, Gary H. ;

Francis, Charles W. .

BLOOD, 2008, 111 (10) :4902-4907

[5] Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer [J].

Maraveyas, A. ;

Waters, J. ;

Roy, R. ;

Fyfe, D. ;

Propper, D. ;

Lofts, F. ;

Sgouros, J. ;

Gardiner, E. ;

Wedgwood, K. ;

Ettelaie, C. ;

Bozas, G. .

EUROPEAN JOURNAL OF CANCER, 2012, 48 (09) :1283-1292

[6] Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model [J].

Munoz Martin, A. J. ;

Garcia Alfonso, P. ;

Ruperez Blanco, A. B. ;

Perez Ramirez, S. ;

Blanco Codesido, M. ;

Martin Jimenez, M. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (10) :927-930

[7] Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy? [J].

Pelzer, U. ;

Sinn, M. ;

Stieler, J. ;

Riess, H. .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (41) :2084-2088

[8] Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial [J].

Pelzer, Uwe ;

Opitz, Bernhard ;

Deutschinoff, Gerd ;

Stauch, Martina ;

Reitzig, Peter C. ;

Hahnfeld, Sabine ;

Mueller, Lothar ;

Grunewald, Martina ;

Stieler, Jens M. ;

Sinn, Marianne ;

Denecke, Timm ;

Bischoff, Sven ;

Oettle, Helmut ;

Doerken, Bernd ;

Riess, Hanno .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) :2028-+

[9] Epidemiology of cancer-associated venous thrombosis [J].

Timp, Jasmijn F. ;

Braekkan, Sigrid K. ;

Versteeg, Henri H. ;

Cannegieter, Suzanne C. .

BLOOD, 2013, 122 (10) :1712-1723

[10] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score [J].

Verso, Melina ;

Agnelli, Giancarlo ;

Barni, Sandro ;

Gasparini, Giampietro ;

LaBianca, Roberto .

INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (03) :291-292

← 1 →